LNTH — Lantheus Holdings Inc · P/E 23, rev $765.5M

Lantheus Holdings Inc (LNTH) is a drug manufacturers - specialty & generic company listed on US.

Latest reported LNTH revenue for 2026-06-30 was $765.5M. Net income was $193.4M. LNTH currently screens at market cap $5.56B and trailing P/E 22.9.

Use this LNTH page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LNTH quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LNTH SEC filings page. Lician reads the product cache first so this HTML stays unique to Lantheus Holdings Inc even when a live quote feed is slow.

Lantheus Holdings Inc latest statements (FY2025)

Latest cached year on this hub. Full LNTH income, balance, and cash tables.

  • Revenue$1.54B
  • Net Income$233.6M
  • Total Assets$2.23B
  • Total Debt$568.7M
  • Free Cash Flow$354.1M

LNTH recent filings